Bank of America’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-19
Closed -$2 8581
2022
Q4
$2 Buy
+19
New +$12 ﹤0.01% 8172
2022
Q3
Sell
-45
Closed 8424
2022
Q2
$0 Sell
45
-42
-48% -$102 ﹤0.01% 8676
2022
Q1
$0 Sell
87
-9,495
-99% -$46.6K ﹤0.01% 9017
2021
Q4
$83K Buy
+9,582
New +$61K ﹤0.01% 6971
2021
Q3
Sell
-100
Closed -$1K 8543
2021
Q2
$1K Sell
100
-24,676
-100% -$156K ﹤0.01% 7684
2021
Q1
$300K Buy
+24,776
New +$491K ﹤0.01% 5742

Other funds holding LHDX

Bank of America's LHDX Position: Q1 2023 in Review

Bank of America sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2023, closing a stake of 19 shares — an estimated $2 sold.

Bank of America first reported a position in LHDX in Q1 2021 and held it in 6 quarters. The position peaked at $300K in Q1 2021. 6 funds tracked by Wall St. Rank hold LHDX as of Q1 2023.

  • Bank of America reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Bank of America sold 19 Lucira Health, Inc. Common Stock shares in Q1 2023, an estimated $2.
  • Bank of America first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • Bank of America's Lucira Health, Inc. Common Stock position peaked at $300K in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2023.

Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.